Neuronetics Inc. (STIM) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Neuronetics Inc. (STIM)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.14

-0.20 (-8.55%)

At close: Jan 14, 2025, 3:59 PM

2.12

-0.93%

Pre-market Jan 15, 2025, 06:01 AM EST

undefined% (undefined)

Bid	2.1
Market Cap	68.63M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.22
PE Ratio (ttm)	-1.75
Forward PE	n/a
Analyst	Buy

Ask	2.25
Volume	1,270,153
Avg. Volume (20D)	593,906
Open	2.22
Previous Close	2.34
Day's Range	1.96 - 2.24
52-Week Range	0.52 - 5.07
Beta	undefined

About STIM

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, ...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Jun 28, 2018

Employees 203

Stock Exchange NASDAQ

Ticker Symbol STIM

Website https://www.neurostar.com

Analyst Forecast

According to 4 analyst ratings, the average rating for STIM stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 40.19% from the latest price.

Buy 75.00%

Hold 25.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Neuronetics Inc. is scheduled to release its earnings on Mar 4, 2025, before market opens.
Analysts project revenue of $18.98M, reflecting a -6.57% YoY shrinking and earnings per share of -0.24, making a 26.32% increase YoY.

Why Price Moved

2 days ago · Source

+36.84%

Neurtonetics shares are trading higher after the c... Unlock content with Pro Subscription

2 months ago · Source

-37.27%

Neuronetics shares are trading lower after the company reported worse-than-expected Q3 financial result and cut its FY24 sales guidance. Also, the company issued Q4 sales guidance below estimates.

News

2 months ago · seekingalpha.com

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

Neuronetics, Inc. (NASDAQ:STIM ) Q3 2024 Earnings Call November 12, 2024 8:30 AM ET Company Participants Mark Klausner - Investor Relations Keith Sullivan - President and Chief Executive Officer Steve...

2 months ago · zacks.com

Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates

Neuronetics (STIM) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.33 per share a year ago.